These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2513010)

  • 1. Factor V: a prototype pro-cofactor for vitamin K-dependent enzyme complexes in blood clotting.
    Jenny RJ; Mann KG
    Baillieres Clin Haematol; 1989 Oct; 2(4):919-44. PubMed ID: 2513010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly of prothrombinase complex.
    Krishnaswamy S; Nesheim ME; Pryzdial EL; Mann KG
    Methods Enzymol; 1993; 222():260-80. PubMed ID: 8412798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal formation of the prothrombinase complex: factor V deficiency and related disorders.
    Tracy PB; Mann KG
    Hum Pathol; 1987 Feb; 18(2):162-9. PubMed ID: 3804320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
    Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of human coagulation factor Va with platelets.
    Kane WH; Majerus PW
    J Biol Chem; 1982 Apr; 257(7):3963-9. PubMed ID: 7061520
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system.
    Hayashi T; Nishioka J; Suzuki K
    Biochim Biophys Acta; 1995 Dec; 1272(3):159-67. PubMed ID: 8541347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative features of the structure, function and modulation of prothrombinase.
    Nesheim ME
    Surv Synth Pathol Res; 1984; 3(3):219-32. PubMed ID: 6387851
    [No Abstract]   [Full Text] [Related]  

  • 10. Purification and characterization of a variant of human prothrombin: prothrombin Segovia.
    Collados MT; Fernández J; Páramo JA; Montes R; Borbolla JR; Montaño LF; Rocha E
    Thromb Res; 1997 Mar; 85(6):465-77. PubMed ID: 9101639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of factor V in the assembly of the prothrombinase complex.
    Mann KG; Nesheim ME; Hibbard LS; Tracy PB
    Ann N Y Acad Sci; 1981; 370():378-88. PubMed ID: 7023322
    [No Abstract]   [Full Text] [Related]  

  • 12. Assembly of the prothrombinase complex in the absence of prothrombin.
    Nesheim ME; Eid S; Mann KG
    J Biol Chem; 1981 Oct; 256(19):9874-82. PubMed ID: 7275986
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of accessory components in the activation of vitamin K-dependent coagulation factors.
    van Rijn JL; Zwaal RF; Hemker HC; Rosing J
    Haemostasis; 1986; 16(3-4):216-26. PubMed ID: 3093336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Clotspeed," a mathematical simulation of the functional properties of prothrombinase.
    Nesheim ME; Tracy RP; Mann KG
    J Biol Chem; 1984 Feb; 259(3):1447-53. PubMed ID: 6693415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of coagulation factor V by calcium-dependent proteinase.
    Rodgers GM; Cong JY; Goll DE; Kane WH
    Biochim Biophys Acta; 1987 Jul; 929(3):263-70. PubMed ID: 3038196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of blood clotting factor V in the conversion of prothrombin and a decarboxy prothrombin into thrombin.
    Vermeer C; Govers-Riemslag JW; Soute BA; Lindhout MJ; Kop J; Hemker HC
    Biochim Biophys Acta; 1978 Feb; 538(3):521-33. PubMed ID: 564211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
    Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
    Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of factor Xa-mediated procoagulant activity of human lung fibroblasts and pleural mesothelial cells.
    Kumar A; Koenig KB; Johnson AR; Fair DS; Idell S
    Eur Respir J; 1995 Dec; 8(12):2038-45. PubMed ID: 8666098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a binding site for blood coagulation factor Xa on the heavy chain of factor Va. Amino acid residues 323-331 of factor V represent an interactive site for activated factor X.
    Kalafatis M; Beck DO
    Biochemistry; 2002 Oct; 41(42):12715-28. PubMed ID: 12379114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human factor V by factor Xa and thrombin.
    Monkovic DD; Tracy PB
    Biochemistry; 1990 Feb; 29(5):1118-28. PubMed ID: 2322551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.